| 1 |
33045974 | Studying the Anti-Tumor Effects of siRNA Gene Silencing of Some Metabolic Genes in Pancreatic Ductal Adenocarcinoma. | 2021 Oct 25 |
2 |
| 2 |
33830713 | VHH212 nanobody targeting the hypoxia-inducible factor 1α suppresses angiogenesis and potentiates gemcitabine therapy in pancreatic cancer in vivo. | 2021 Apr 8 |
2 |
| 3 |
34593522 | LncRNA HIF1A-AS1 Promotes Gemcitabine Resistance of Pancreatic Cancer by Enhancing Glycolysis through Modulating the AKT/YB1/HIF1α Pathway. | 2021 Nov 15 |
4 |
| 4 |
32226541 | IL-37/ STAT3/ HIF-1α negative feedback signaling drives gemcitabine resistance in pancreatic cancer. | 2020 |
2 |
| 5 |
32819602 | In vitro affinity maturation to improve the efficacy of a hypoxia-inducible factor 1α single-domain intrabody. | 2020 Sep 3 |
1 |
| 6 |
33052979 | Quercetin potentializes the respective cytotoxic activity of gemcitabine or doxorubicin on 3D culture of AsPC-1 or HepG2 cells, through the inhibition of HIF-1α and MDR1. | 2020 |
1 |
| 7 |
30628067 | Rg3 inhibits gemcitabine-induced lung cancer cell invasiveness through ROS-dependent, NF-κB- and HIF-1α-mediated downregulation of PTX3. | 2019 Jul |
1 |
| 8 |
31565190 | Correction: Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma. | 2019 Sep 17 |
1 |
| 9 |
29693166 | Hypoxia-induced autophagy promotes gemcitabine resistance in human bladder cancer cells through hypoxia-inducible factor 1α activation. | 2018 Jul |
3 |
| 10 |
29772221 | miR-301a plays a pivotal role in hypoxia-induced gemcitabine resistance in pancreatic cancer. | 2018 Aug 1 |
1 |
| 11 |
29953500 | Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells. | 2018 |
1 |
| 12 |
26785721 | Hypoxia regulates ABCG2 activity through the activivation of ERK1/2/HIF-1α and contributes to chemoresistance in pancreatic cancer cells. | 2016 |
1 |
| 13 |
25678112 | Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer. | 2015 Apr |
2 |
| 14 |
24535079 | Effects of the HIF-1α and NF-κB loop on epithelial-mesenchymal transition and chemoresistance induced by hypoxia in pancreatic cancer cells. | 2014 Apr |
1 |
| 15 |
24575976 | Gemcitabine resistance is associated with epithelial-mesenchymal transition and induction of HIF-1α in pancreatic cancer cells. | 2014 |
6 |
| 16 |
23579097 | BLU enhances the effects of anti-angiogenic activity in combination with gemcitabine-based chemotherapeutic agents. | 2013 Jul |
1 |
| 17 |
23740244 | An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor κB- and hypoxia-inducible factor 1α-mediated up-regulation of CXCR4. | 2013 Jul 19 |
5 |
| 18 |
21839751 | CCK-2/gastrin receptor signaling pathway is significant for gemcitabine-induced gene expression of VEGF in pancreatic carcinoma cells. | 2011 Oct 24 |
2 |
| 19 |
21922147 | Hypoxia-inducible factor-1α expression and gemcitabine chemotherapy for pancreatic cancer. | 2011 Dec |
2 |
| 20 |
22993609 | Gemcitabine and paclitaxel suppress the production of vascular endothelial growth factor induced by deferoxamine in human non-small cell lung cancer A549 cells. | 2010 Sep |
2 |
| 21 |
15845181 | Clinical significance of hypoxia-inducible factor-1a messenger RNA expression in locally advanced non-small-cell lung cancer after platinum agent and gemcitabine chemotherapy followed by surgery. | 2005 Mar |
3 |